Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

A Rare Case of Transformation of Childhood Myelodysplastic Syndrome to Acute Lymphoblastic Leukemia

  • Koh, Young Rae (Department of Laboratory Medicine, Pusan National University School of Medicine and Pusan National University Hospital) ;
  • Cho, Eun Hae (Greencross Reference Laboratory) ;
  • Park, Seong Shik (Department of Pediatrics, Pusan National University Yangsan Hospital) ;
  • Park, Mi Young (Department of Laboratory Medicine, Pusan National University Yangsan Hospital) ;
  • Lee, Sun Min (Department of Laboratory Medicine, Pusan National University Yangsan Hospital) ;
  • Kim, In Suk (Department of Laboratory Medicine, Pusan National University School of Medicine and Pusan National University Hospital) ;
  • Lee, Eun Yup (Department of Laboratory Medicine, Pusan National University School of Medicine and Pusan National University Hospital)
  • Published : 2013.03.02
⟨ Previous Next ⟩

Abstract

Transformation of MDS into ALL during childhood is extremely rare. We report a rare case of an 8-yr-old girl who presented with refractory cytopenia of childhood (RCC) that transformed into ALL only 3 months after the diagnosis of childhood MDS. Although no cytogenetic abnormalities were observed in conventional karyotype and FISH analysis, we found several deletions on chromosomes 5q, 12q, 13q, and 22q. Partial homozygous deletion of the RB1 gene was observed on microarray analysis, with the bone marrow specimen diagnosed as ALL. This is the first case report of transformation of ALL from childhood MDS in Korea. We also compared the clinical, cytological, and cytogenetic features of 4 previously reported childhood MDS cases that transformed into ALL.

Keywords

References

  1. Kouides PA and Bennett JM. Understanding the myelodysplastic syndromes. Oncologist 1997;2:389-401.
  2. Malcovati L and Nimer SD. Myelodysplastic syndromes: diagnosis and staging. Cancer Control 2008;15:4-13.
  3. Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer 2007;109:1536-42. https://doi.org/10.1002/cncr.22570
  4. Niemeyer CM, Kratz CP, Hasle H. Pediatric myelodysplastic syndromes. Curr Treat Options Oncol 2005;6:209-14. https://doi.org/10.1007/s11864-005-0004-3
  5. Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003;17:277-82. https://doi.org/10.1038/sj.leu.2402765
  6. Germing U, Aul C, Niemeyer CM, Haas R, Bennett JM. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Ann Hematol 2008;87:691-9. https://doi.org/10.1007/s00277-008-0499-3
  7. Disperati P, Ichim CV, Tkachuk D, Chun K, Schuh AC, Wells RA. Progression of myelodysplasia to acute lymphoblastic leukaemia: Implications for disease biology. Leuk Res 2006;30:233-9. https://doi.org/10.1016/j.leukres.2005.06.011
  8. Bader-Meunier B, Miélot F, Tchernia G, Buisine J, Delsol G, Duchayne E, et al. Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study. French Society of Paediatric Haematology and Immunology. Br J Haematol 1996;92:344-50.
  9. Goel R, Kumar R, Bakhshi S. Transformation of childhood MDS-refractory anemia to acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2007;29:725-7. https://doi.org/10.1097/MPH.0b013e31814d6959
  10. Gupta V and Bhatia B. Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia in a child. Indian J Hematol Blood Transfus 2010;26:111-3. https://doi.org/10.1007/s12288-010-0015-5
  11. Janssen JW, Buschle M, Layton M, Drexler HG, Lyons J, Berghe H, et al. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 1989;73:248-54.
  12. San Miguel JF, Hernandez JM, Gonzalez-Sarmiento R, Gonzalez M, Sanchez I, Orfao A, et al. Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics. Blood 1991;78:768-74.
  13. Orfao A, Ortuno F, Santiago M, Lopez A, San Miguel J. Immunophenotyping of acute leukemias and myelodysplastic syndromes. Cytometry A 2004;58:62-71.
  14. Fujii S, Shimizu K, Klimek V, Geller MD, Nimer SD, Dhodapkar MV. Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes. Br J Haematol 2003;122:617-22. https://doi.org/10.1046/j.1365-2141.2003.04465.x
  15. Amin HM, Jilani I, Estey EH, Keating MJ, Dey AL, Manshouri T. Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome. Blood 2003;102:1866-8. https://doi.org/10.1182/blood-2003-01-0221
  16. Span LFR, Vierwinden G, Pennings AH, Boezeman JB, Raymakers RA, de Witte T. Programmed cell death is an intrinsic feature of MDS progenitors, predominantly found in the cluster-forming cells. Exp Hematol 2005;33:435-42. https://doi.org/10.1016/j.exphem.2004.12.009
  17. Abruzzese E, Buss D, Rainer R, Pettenati MJ, Rao PN. Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukemia: a case report and cell lineage study. Ann Hematol 1996;73:35-8. https://doi.org/10.1007/s002770050197
  18. Kohno T, Amenomori T, Atogami S, Sasagawa I, Nakamura H, Kuriyama K, et al. Progression from myelodysplastic syndrome to acute lymphoblastic leukemia with Philadelphia chromosome and p190 BCR-ABL transcript. Br J Haematol 1996;93:389-91. https://doi.org/10.1046/j.1365-2141.1996.4931034.x
  19. Lima CS, de Souza CA, Cardinalli IA, Lorand-Metze I. Lymphoblastic transformation of myelodysplastic syndrome. Sao Paulo Med J 1997;115:1508-12. https://doi.org/10.1590/S1516-31801997000400009
  20. Sato N, Nakazato T, Kizaki M, Ikeda Y, Okamoto S. Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: a case report and review of the literature. Int J Hematol 2004;79:147-51. https://doi.org/10.1532/IJH97.03137
  21. Zainina S and Cheong SK. Myelodysplastic syndrome transformed into Acute Lymphoblastic Leukemia (FAB:L3). Clin Lab Haematol 2006;28:282-3. https://doi.org/10.1111/j.1365-2257.2006.00800.x
  22. Serefhanoglu S, Goker H, Buyukasik Y, Sayinalp N, Ozcebe OI. Transformation of adult myelodysplastic syndrome-refractory anemia to acute T-cell lymphoblastic leukemia. J Natl Med Assoc 2009;101:370-2. https://doi.org/10.1016/S0027-9684(15)30887-7
  23. Niemeyer CM and Baumann I. Classification of childhood aplastic anemia and myelodysplastic syndrome. Hematology Am Soc Hematol Educ Program 2011;2011:84-9. https://doi.org/10.1182/asheducation-2011.1.84
  24. Bejar R, Levine R, Ebert BL. Unraveling the molecular pathophysiology of myelodysplastic syndromes. J Clin Oncol 2011;29:504-15. https://doi.org/10.1200/JCO.2010.31.1175
  25. Teachey DT. Lymphoproliferative disorders, myelodysplastic syndromes and myeloproliferative disorders. In: Lanzkowsky P, ed. Manual of pediatric hematology and oncology. 5th ed. London: Academic Press, 2010:494-503.
  26. Hasle H, Baumann I, Bergstrasser E, Fenu S, Fischer A, Kardos G, et al. The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML). Leukemia 2004;18:2008-14. https://doi.org/10.1038/sj.leu.2403489

Cited by

  1. De Novo 13q13.3-21.31 deletion involving RB1 gene in a patient with hemangioendothelioma of the liver vol.40, pp.1, 2013, https://doi.org/10.1186/1824-7288-40-5
  2. Acute pro-B-Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review vol.15, pp.6, 2013, https://doi.org/10.3892/ol.2018.8546
  3. Lymphoblastic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms vol.60, pp.12, 2019, https://doi.org/10.1080/10428194.2019.1605509
  4. Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia vol.100, pp.1, 2013, https://doi.org/10.1007/s00277-020-04114-2
  5. Myelodysplastic syndrome transformed into B-lineage acute lymphoblastic leukemia: A case report vol.9, pp.19, 2013, https://doi.org/10.12998/wjcc.v9.i19.5191